Research study Program year 2021 Source: CMS Open Payments

1st Line CRC

Research payments

$4,933

9 payments

Through program year 2021, $4,933 in research payments was reported against 1st Line CRC, across 9 payments, paid by Amgen Inc..

Paid by: Amgen Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2021	Research	$1,686	7
2020	Research	$3,246	2

Breakdown

Who paid Research payments · program years 2020–2021

Amgen Inc. $4,933 9 payments

Who received the money Research payments · program years 2020–2021

Christine Parseghian Medical Oncology · Houston, TX $1,864 2 payments
Marwan Fakih Medical Oncology · Duarte, CA $1,623 1 payment
Kanwal Raghav Medical Oncology · Houston, TX $241 1 payment
Eduardo Vilar Sanchez Medical Oncology · Houston, TX $241 1 payment
Jason Henry Internal Medicine · Denver, CO $241 1 payment
Edmund Kopetz Medical Oncology · Houston, TX $241 1 payment
Van Morris Durham, NC $241 1 payment
Jason Willis Medical Oncology · Houston, TX $241 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.